27844448|t|miR-27b inhibits gastric cancer metastasis by targeting NR2F2
27844448|a|Increasing attention is focused on the down-regulation of miRNAs in cancer process. Nuclear receptor subfamily 2 (NR2F2, also known as COUP-TFII) is involved in the development of many types of cancers, but its role in gastric cancer remains elusive. In this experiment, oncomine and Kaplan-meier database revealed that NR2F2 was up-regulated in gastric cancer and that the high NR2F2 expression contributed to poor survival. MicroRNA-27b was targeted and down-regulated by NR2F2 in human gastric cancer tissues and cells. The ectopic expression of miR-27b inhibited gastric cancer cell proliferation and tumor growth in vitro and in vivo. Assays suggested that the overexpression of miR-27b could promote MGC-803 cells ' migration and invasion and retard their metastasis to the liver. In addition, down-regulation of miR-27b enhanced GES-1 cells ' proliferation and metastasis in vitro. These findings reveal that miR-27b is a tumor suppressor in gastric cancer and a biomarker for improving patients ' survival.
27844448	0	7	miR-27b	T028	C1537730
27844448	8	16	inhibits	T052	C3463820
27844448	17	31	gastric cancer	T191	C0699791
27844448	32	42	metastasis	T191	C0027627
27844448	46	55	targeting	T169	C1521840
27844448	56	61	NR2F2	T116,T192	C1506576
27844448	62	72	Increasing	T169	C0442808
27844448	73	82	attention	T041	C0004268
27844448	101	116	down-regulation	T044	C0013081
27844448	120	126	miRNAs	T114,T123	C1101610
27844448	130	144	cancer process	T191	C0007097
27844448	146	174	Nuclear receptor subfamily 2	T116,T192	C1506576
27844448	176	181	NR2F2	T116,T192	C1506576
27844448	197	206	COUP-TFII	T116,T192	C1506576
27844448	211	219	involved	T169	C1314939
27844448	227	238	development	T169	C1527148
27844448	247	252	types	T080	C0332307
27844448	256	263	cancers	T191	C0007097
27844448	273	277	role	T077	C1705810
27844448	281	295	gastric cancer	T191	C0699791
27844448	321	331	experiment	T062	C0681814
27844448	333	341	oncomine	T170	C0242356
27844448	346	367	Kaplan-meier database	T170	C0242356
27844448	368	376	revealed	T080	C0443289
27844448	382	387	NR2F2	T116,T192	C1506576
27844448	392	404	up-regulated	T044	C0041904
27844448	408	422	gastric cancer	T191	C0699791
27844448	436	440	high	T080	C0205250
27844448	441	446	NR2F2	T116,T192	C1506576
27844448	447	457	expression	T045	C1171362
27844448	458	469	contributed	T052	C1880177
27844448	473	477	poor	T080	C0542537
27844448	478	486	survival	T081	C0038954
27844448	488	500	MicroRNA-27b	T028	C1537730
27844448	505	513	targeted	T169	C1521840
27844448	518	532	down-regulated	T044	C0013081
27844448	536	541	NR2F2	T116,T192	C1506576
27844448	545	550	human	T016	C0086418
27844448	551	565	gastric cancer	T191	C0699791
27844448	566	573	tissues	T024	C0040300
27844448	578	583	cells	T025	C1518174
27844448	589	607	ectopic expression	T045	C1512167
27844448	611	618	miR-27b	T028	C1537730
27844448	619	628	inhibited	T080	C0311403
27844448	629	643	gastric cancer	T191	C0699791
27844448	644	662	cell proliferation	T043	C0596290
27844448	667	679	tumor growth	T191	C0598934
27844448	680	688	in vitro	T080	C1533691
27844448	693	700	in vivo	T082	C1515655
27844448	702	708	Assays	T059	C0005507
27844448	709	718	suggested	T078	C1705535
27844448	728	742	overexpression	T045	C0017262
27844448	746	753	miR-27b	T028	C1537730
27844448	760	767	promote	T052	C0033414
27844448	768	781	MGC-803 cells	T025	C0007634
27844448	784	793	migration	T043	C1622501
27844448	798	806	invasion	T046	C2699153
27844448	811	817	retard	T080	C0521111
27844448	824	834	metastasis	T191	C0027627
27844448	842	847	liver	T023	C0023884
27844448	862	877	down-regulation	T044	C0013081
27844448	881	888	miR-27b	T028	C1537730
27844448	898	909	GES-1 cells	T025	C0007634
27844448	912	925	proliferation	T043	C0596290
27844448	930	940	metastasis	T191	C0027627
27844448	941	949	in vitro	T080	C1533691
27844448	957	965	findings	T033	C0243095
27844448	966	972	reveal	T080	C0443289
27844448	978	985	miR-27b	T028	C1537730
27844448	991	1007	tumor suppressor	T028	C0079427
27844448	1011	1025	gastric cancer	T191	C0699791
27844448	1032	1041	biomarker	T201	C0005516
27844448	1046	1055	improving	T080	C1272745
27844448	1056	1064	patients	T101	C0030705
27844448	1067	1075	survival	T081	C0038954